Navigation Links
deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
Date:4/24/2008

borative relationships, uncertainty regarding potential future deterioration in the market for auction rate securities which could result in additional permanent impairment charges, our ability to develop and market diagnostic products, the level of third party reimbursement for our products, risks related to preclinical and clinical development of pharmaceutical products, including the identification of compounds and the completion of clinical trials, the effect of government regulation and the regulatory approval processes, market acceptance, our ability to obtain and protect intellectual property rights for our products, dependence on collaborative relationships, the effect of competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10-K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.

Contacts:

deCODE genetics

Gisli Arnason

+354 570 1825

gisli.arnason@decode.is


'/>"/>
SOURCE deCODE genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. deCODE Launches deCODEme(TM)
5. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
6. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
7. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
8. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
9. deCODE Genetics Announces Full-year 2007 Financial Results
10. deCODE genetics to Webcast Presentation at Lehman Brothers Eleventh Annual Global Healthcare Conference
11. deCODE genetics to Webcast Presentation at 15th Annual Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 Stemline Therapeutics, Inc. today announced that data from ... in both in vitro and animal models of ... presentation at the upcoming 51st Annual Meeting of the American ... from December 5-8, 2009. The poster will be presented by ...
(Date:12/3/2009)... JourneyLite of Houston, LLC announced today ... a second surgical option, vertical sleeve gastrectomy , ... currently performs. The first sleeve gastrectomy procedure at the ... Laurent, MD on October 20, 2009. The patient ...
(Date:12/3/2009)... PHARMACEUTICALS, INC. (OTC Bulletin Board: ... launch of MuGard, an FDA approved treatment for oral ... chemotherapy. MuGard is commercially launched by Access, partner, SpePharm, ... Norway, Greece and Sweden. Access is conducting pre-marketing activities, ...
(Date:12/3/2009)... Shire plc (LSE: SHP, Nasdaq: SHPGY ), the ... of five lots and voluntary market withdrawal of one ... . Shire is taking this action because some Daytrana ... not meet their release liner removal specification, and as ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5
... CHAPEL HILL, N.C., June 10 Pharmaceutical companies ... dollars in the lifetime cash,flows of potential mega-brands. ... value of a new product. Sales and Marketing ... the table at which market success is,determined., ...
... June 10 Barr Pharmaceuticals,Inc. (NYSE: BRL ... has initiated a challenge of the patents listed ... SoluTab(TM),Delayed-Release Orally Disintegrating Tablets (lansoprazole), 15mg and,30mg., ... containing a,paragraph IV certification for a generic Prevacid ...
... Bioheart, Inc.,(Nasdaq: BHRT ) today announced that it ... stock to the Nasdaq Capital Market. The Company,s,common stock ... The,Nasdaq Capital Market at the opening of business on ... tier of the Nasdaq Stock Market for,companies with a ...
Other Biology Technology:Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg 2Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg 3Bioheart, Inc. to Transfer to Nasdaq Capital Market 2
(Date:12/3/2009)... Dec. 3 BIO-key International, Inc. (OTC Bulletin ... and finger-based biometric identification solutions, announced that a ... Meeting held today approved the sale of the ... Inc. Of the shares voted, 98.6% were cast ...
(Date:12/3/2009)... or solar panels that repels grime and dirt? Expanded ... Tel Aviv University research, just published in Nature ... the nano-scale level that could make these futuristic visions ... in the range of 100 nanometers (roughly one-billionth of ...
(Date:12/3/2009)... Grand Rapids, Mich. (Dec. 3, 2009) Van ... plant hormone abscisic acid (ABA) works at the molecular level ... and cold. Their findings, published in the journal ... environments around the world and combat global food shortages. ...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 1Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 2Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 3Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 4Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 5Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 6Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 7Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 8Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 9Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 10Encorium Reports Third Quarter 2009 Financial Results 3B Announces Date of Annual Stockholder Meeting 61477 11Finding a protective mechanism for retinal cells could save sight 14859 1Finding a protective mechanism for retinal cells could save sight 14859 2Bacterial ropes tie down shifting Southwest 10753 1Bacterial ropes tie down shifting Southwest 10753 2
... Syracuse University and the Serum Institute of India could ... living in some of the most impoverished areas of ... a team of SU researchers led by Robert Doyle, ... and Sciences, to develop new oral vaccines against tetanus ...
... Huntsville, Ala. -- A team including researchers at ... colleagues from a number of other organizations, today ... the brain cancer glioblastoma. These results are the ... network, a collaborative effort funded by the National ...
... (Sept. 4, 2008) A variety of organismsfrom ... where the timing and duration of fundamental biological processes ... survive, even under fluctuating environmental conditions. In recent ... molecular basis of these rhythms and how they translate ...
Other Biology News:Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4Collaboration between researchers yields more comprehensive portrait of brain cancer 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
... Designed to meet the needs ... animal component-free medium supports fast ... cell densities, while maintaining high ... protein production using the Baculovirus ...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
... LIC Duet™ Trx•Tag™ Ek Adaptor encodes a ... binding site (rbs), ATG translation initation codon, ... Trx•Tag is a 109 aa sequence that ... been demonstrated to enhance solubility of many ...
Biology Products: